News Focus
News Focus
icon url

biosectinvestor

07/20/24 3:41 PM

#707300 RE: Nemesis18 #707299

We know what is going on. It is a single product company in the midst of an approval, now with multiple new potential trials and drugs because of the recent deal they made with a top cancer center in their field, a major vote of confidence.

They have a licensed manufacturing facility and are allowed to provide the product on a compassionate basis after a successful phase 3 and they have stunning results from that trial and a secondary combination trial in major journals, JAMA Oncology and Nature, both peer reviewed.

What exactly do you have. You still can’t tell us all of it, just your fake hints.
icon url

XMaster2023

07/20/24 3:51 PM

#707302 RE: Nemesis18 #707299

The longs have thought long and hard about the interim data at the end of each phase of the trial. We were here before Flaskworks and the law suit. We have listened to Brad Silver and we know LP and LL’s objectives. So when you say we refuse to confront “issues” your wrong as we have done more Due Diligence than your boss.

If I was you, I would be wondering one thing. Who is going to tender my defense. You don’t have any Immunity. I hope you enjoy being in a cell with Bubba. Do your Due Diligence.